The Valley Desk

ArticleJAAD internationalPublished

Deucravacitinib for the treatment of moderate-to-severe palmoplantar pustulosis: Results from an early-terminated open-label trial

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
JAAD international
Published
Subject terms
Psoriasis; Palmoplantar Pustulosis; Clinical Trial; Deucravacitinib
PubMed ID
41552704
PubMed Central ID
PMC12805082
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal